Skip to main content

Table 1 Patient demographic and clinical characteristics of consenters (by study arm) and decliners

From: Nurse-led group consultation intervention reduces depressive symptoms in men with localised prostate cancer: a cluster randomised controlled trial

 

Consenters

  

P

Usual care

Intervention

Decliners

(N = 166)

(N = 165)

(N = 115)

n

%

n

%

n

%

Oncology facility

      

0.02

 Site 1

70

42.2

70

42.4

64

55.7

 

 Site 2

96

57.8

95

57.6

51

44.3

 

Age at baseline, years

      

0.30

 Mean

67.6

67.2

68.1

 

 Standard Deviation

6.7

6.9

7.9

 

Range

46–85

51–84

44–82

 

 <65

54

32.5

56

33.9

32

27.8

 

 ≥65

112

67.5

109

66.1

83

72.2

 

Marital status

 Married/defacto

136

81.9

127

77.0

   

 Other

30

18.1

38

23.0

   

Location

      

0.14

 Urban

136

81.9

136

82.4

101

87.8

 

 Rural

30

18.1

29

17.6

13

11.3

 

 Missing

    

1

  

Risk group (D’Amico, 1998)

      

0.16

 Low

11

10.6

11

11.6

4

3.9

 

 Intermediate

44

42.3

39

41.1

37

35.9

 

 High

49

47.1

45

47.4

38

36.9

 

Scheduled treatment

      

0.29

 Salvage EBRT

61

36.7

69

41.8

31

27.0

 

 Brachytherapy followed by EBRT

8

4.8

9

5.5

8

7.0

 

 EBRT followed by brachytherapy

5

3.0

3

1.8

1

0.9

 

 EBRT alone

92

55.4

84

50.9

70

60.9

 

Previous treatment

 Any previous treatment

      

0.60

  No

39

23.5

34

20.6

28

24.3

 

  Yes

127

76.5

131

79.4

87

75.7

 

 Active surveillance

      

1.00

  No

148

89.2

153

92.7

105

91.3

 

  Yes

18

10.8

12

7.3

10

8.7

 

 Prostatectomy

      

0.15

  No

105

63.3

96

58.2

79

68.7

 

  Yes

61

36.7

69

41.8

36

31.3

 

 Androgen deprivation

      

0.49

  No

113

68.1

116

70.3

75

65.2

 

  Yes

53

31.9

49

29.7

40

34.8

 
  1. P-value relates to comparison of consenters versus decliners. Other marital status includes never married, separated/divorced and widowed. Risk groups were designated for men who did not undergo surgery
  2. EBRT external beam radiotherapy, TURP transurethral resection of the prostate